SPEAKER_01 0:00

Imagine looking at an x-ray of a broken arm, right? But the jagged white fracture line, it just sort of disappears depending on what time of day it is, or uh how stressed you are, or whether you just jogged up a flight of stairs.

SPEAKER_00 0:12

Which sounds completely like science fiction.

SPEAKER_01 0:14

Exactly. I mean, we expect our medical diagnoses to be precise, like pass or fail, broken or not broken.

SPEAKER_00 0:20

Right, yeah.

SPEAKER_01 0:21

But for the millions of people navigating bleeding disorders, that moving target is just their daily reality. We are looking at a diagnostic landscape that is, honestly, incredibly murky.

SPEAKER_00 0:32

Murky is probably the best word for it, yeah.

SPEAKER_01 0:35

Welcome to today's deep dive. Our mission today is exploring this truly fascinating text by William Ayrd, and it's titled Type 1 VWD: Navigating the Quantitative Thresholds of Bleeding Risk. And the core mystery we're trying to solve for you today is basically this: what happens when a disease isn't defined by a simple positive or negative test, but by this, you know, moving target of numbers, biology, and life circumstances.

SPEAKER_00 0:58

Yeah. And to really understand why this is such a moving target, we first need to look at what von Willebrand disease or VWD actually is mechanically. Right. So at a high level, von Willebrand factor, which we'll just call VWF to keep it simple, is a crucial protein in your blood. Okay. When you're injured, it acts like a, well, like a biological glue that helps your platelets stick together and form a clot.

SPEAKER_01 1:23

So it's the glue.

SPEAKER_00 1:24

Exactly. VWD is the most common inherited bleeding disorder, and today we're focusing specifically on type one, which is characterized by a partial quantitative deficiency of this protein.

SPEAKER_01 1:36

Aaron Powell Okay, let's unpack this. We have this glue protein, we need it to clot, and in type one, we just don't have enough of it. I mean, it sounds simple on the surface.

SPEAKER_00 1:43

It does, yeah.

SPEAKER_01 1:44

But the text makes it really clear that this seemingly simple lone number actually leads to some of the hardest diagnostic questions in all of medicine. We're going to figure out exactly why.

SPEAKER_00 1:54

Well, the complexity really starts right at the laboratory definition. When doctors run a specific panel for type one, they are looking for a very distinct pattern.

SPEAKER_01 2:02

Okay, what kind of pattern?

SPEAKER_00 2:04

First, they measure the VWF antigen, which is basically simply a headcount of the total amount of the protein present in the blood.

SPEAKER_01 2:12

Aaron Powell Got it. So just how much is there?

SPEAKER_00 2:14

Right. And that number will be low. Second, they measure the platelet-dependent activity. Now, this isn't a headcount. This is asking how well the protein that is actually there is working to bind those platelets together.

SPEAKER_01 2:27

Aaron Ross Powell So it's about function.

SPEAKER_00 2:29

Exactly. And that activity number will also be low. But the crucial defining teacher of type one is that the ratio between the activity and the antigen is preserved.

SPEAKER_01 2:38

Aaron Powell Okay, making sure I'm following you here. The protein that is floating around in the bloodstream, it works perfectly fine. Like it's fully functional.

SPEAKER_00 2:46

Yes.

SPEAKER_01 2:46

There's just a smaller physical amount of it available.

SPEAKER_00 2:48

Aaron Powell That is the core of it, yeah. And to add another layer, another clotting protein called factor eight might be completely normal or maybe just mildly reduced.

SPEAKER_01 2:56

Aaron Powell Wait, why is Factor VIII involved now?

SPEAKER_00 2:59

Well, because one of VWF's main jobs is to act as a bodyguard for factor eight in the bloodstream. It literally protects it from being destroyed. Yeah. So as long as you have enough VWF to do the carrying, your factor eight levels can survive just fine. And finally, the multimers, which are the physical chain-like structures of these proteins, are completely normal in their distribution.

SPEAKER_01 3:21

I love a good analogy. So let's think of Von Willebrand factor, like a massive fleet of cars rolling off a factory assembly line.

SPEAKER_00 3:30

Okay, I like where this is going.

SPEAKER_01 3:32

If we were talking about a different variant, say type two VWD, that's a qualitative problem. The cars are being built, but uh the steering wheels are missing. They just don't function right.

SPEAKER_00 3:42

Right.

SPEAKER_01 3:42

And if we were talking about type three, that is a total factory shutdown. Zero cars are being produced.

SPEAKER_00 3:47

Exactly.

SPEAKER_01 3:48

But type one is just a production slowdown. The cars rolling off the line are perfectly good cars, complete with steering wheels and brakes. There just aren't enough of them to handle rush hour traffic.

SPEAKER_00 3:58

That visualization captures the mechanics perfectly. And it also highlights exactly where the medical debate really begins. Because how slow does the factory have to get before we officially call it a disease? There is no biological cliff in the human body where everything is completely fine at 51 units of this protein and then just catastrophic at 49 units. Trevor Burrus, Jr.

SPEAKER_01 4:20

Right. Because everybody's different.

SPEAKER_00 4:21

Trevor Burrus, Jr.: Yeah. VWF levels are continuously distributed across the entire human population.

SPEAKER_01 4:26

Aaron Powell It's less like testing positive for a virus and more like measuring height or blood pressure. There's a bell curve. Yeah. And doctors are trying to figure out exactly where the uh short end of the curve becomes an actual medical liability.

SPEAKER_00 4:38

Trevor Burrus Exactly. And because of that continuous slide, historically the medical community had to just draw a line in the sand.

SPEAKER_01 4:44

Trevor Burrus, Jr.: Where did they draw it?

SPEAKER_00 4:45

Aaron Ross Powell They looked at two distinct thresholds. If your VWF levels fall under 30 IU per DL, the biology is much clearer. We see a direct inverse relationship between that low residual level and a higher bleeding risk.

SPEAKER_01 4:58

Aaron Powell Okay. So under 30 is bad news.

SPEAKER_00 5:00

Aaron Powell Yes. We also see clear familial segregation, meaning the severe shortage tracks predictably through family trees, and we can often identify the specific genetic variants causing the slowdown.

SPEAKER_01 5:11

Aaron Powell But then there's that gray area, right? The 30 to 50 range.

SPEAKER_00 5:15

Aaron Powell Oh, the 30 to 50 IU per DL range is highly heterogeneous. It is a total biological mix. And you mean Well, some people in the specific range bleed significantly and frequently. Some don't bleed at all.

SPEAKER_01 5:26

Aaron Powell Seriously, not at all.

SPEAKER_00 5:27

Aaron Powell Not at all. And for a third group, their bleeding is partly due to the low VWF, but it's also being compounded by other factors entirely, like uh underlying gynecologic or vascular issues.

SPEAKER_01 5:40

Aaron Powell And this brings us to the 2021 diagnostic guidelines from major hematology organizations, groups like ASH, ISTH, NHF, and WFH. They essentially decided to formalize that line in the sand.

SPEAKER_00 5:52

Yes, they did.

SPEAKER_01 5:53

They recommended that anyone whose levels fall under 30 receives the type 1 diagnosis, regardless of whether they are actively experiencing bleeding symptoms.

SPEAKER_00 6:01

Right.

SPEAKER_01 6:01

But for people stuck in that murky 30 to 50 range, they only receive the type 1 label if they have an abnormal bleeding history.

SPEAKER_00 6:08

What's fascinating here is that this guideline choice does a massive amount of good. It improves access to specialized care, uh, patient education, and insurance coverage for treatments for people who desperately need it. But it doesn't erase the biological messiness of that 30 to 50 range. It is ultimately an administrative and clinical tool designed to help patients. It's not a perfect reflection of underlying biology.

SPEAKER_01 6:32

Wait, if the 30 to 50 range is an administrative tool masking a messy biological reality, what is actually moving those numbers around in the first place? I mean, we're not just looking at a static number printed on a piece of lab paper. This is a living, breathing body.

SPEAKER_00 6:48

The human body is incredibly dynamic, and von Willebrand factor is what we call an acute phase reactant.

SPEAKER_01 6:53

Okay, what does that mean?

SPEAKER_00 6:54

This means the levels in your blood don't just sit at one baseline number your entire life. They jump in direct response to physiological changes.

SPEAKER_01 7:02

Like what kind of changes?

SPEAKER_00 7:03

If you are highly stressed, if you are experiencing severe inflammation, if you just finished an intense workout, or if you are pregnant, your body will pump out more VWF and your levels will rise significantly.

SPEAKER_01 7:17

And it gets even wilder than that.

SPEAKER_00 7:18

Yeah.

SPEAKER_01 7:19

Blood type plays a massive role. The text notes that people with type O blood naturally have lower VWF levels on average than people with A B or A B blood type.

SPEAKER_00 7:29

Yes. Blood type is a huge factor.

SPEAKER_01 7:32

Wait, I have to push back on this for a second.

SPEAKER_00 7:34

Okay.

SPEAKER_01 7:34

Let's say I have typo blood, and I just sprinted three blocks to catch a bus before rushing into the clinic to get my blood drawn.

SPEAKER_00 7:40

Okay.

SPEAKER_01 7:40

My numbers are going to look completely different than if I was calmly resting on a Sunday afternoon.

SPEAKER_00 7:45

Oh, absolutely.

SPEAKER_01 7:46

Are we over-diagnosing perfectly healthy typo people with a bleeding disease just because they have a naturally lower baseline on a calm day?

SPEAKER_00 7:54

You are hitting on one of the most critical debates in hematology right now, and your concern is completely valid. A single borderline low lab value in a person who has never had a bleeding symptom absolutely does not prove they have a disease. ABO blood type doesn't explain away abnormal bleeding, but it provides crucial context that helps hematologists interpret the blood level. This is exactly why repeat testing is a biological necessity, not just bureaucratic red tape designed by insurance companies.

SPEAKER_01 8:23

Aaron Powell So taking one snapshot of a moving target is just medically useless.

SPEAKER_00 8:28

Pretty much. A diagnosis should generally be based on repeat testing on two separate occasions. And crucially, those blood draws need to happen when the patient is at a true baseline state of health.

SPEAKER_01 8:39

Meaning no running for the bus.

SPEAKER_00 8:41

Exactly. Not when they are acutely inflamed from a cold, not right after a heavy workout, not during pregnancy, and not right after a surgery.

SPEAKER_01 8:49

Okay, so if the biological stressors can alter the lab result and sprinting for a bus can alter the biology, how on earth does a doctor actually know if you're sick? They can't possibly just rely on a blood draw that is this sensitive.

SPEAKER_00 9:02

They don't. The lab numbers are secondary to the most important diagnostic tool of all, which is the patient's actual lived experience.

SPEAKER_01 9:08

The history.

SPEAKER_00 9:09

Yeah. The bleeding history is central. And we aren't just talking about, you know, a paper cut that bleeds for an extra minute. Doctors are looking for very specific mucosal bleeding signs.

SPEAKER_01 9:19

Likewise.

SPEAKER_00 9:20

This includes frequent epistaxes, which are severe nose bleeds, easy and unexplained bruising, oral cavity bleeding, prolonged bleeding from minor wounds. Wow. Okay. And very importantly, heavy menstrual bleeding, massive bleeding after a dental extraction, and postpartum hemorrhage following childbirth.

SPEAKER_01 9:41

And doctors use these things called bleeding assessment tools or Batesy's to try and quantify this history, right? It's basically a highly structured questionnaire to give a numerical score to your lived experience.

SPEAKER_00 9:52

Yeah, these tools are incredibly helpful to structure the patient history and basically remove some of the subjectivity.

SPEAKER_01 9:58

Right, to make it standardized.

SPEAKER_00 9:59

Exactly. They are particularly helpful when trying to figure out the mathematical likelihood that you have the disease before a doctor even runs a test, what we call the pretest probability.

SPEAKER_01 10:08

Okay, that makes sense.

SPEAKER_00 10:09

If your bat score is very low, it might suggest you don't even need the specific expensive VWD testing. But, and this is a very big but a high score does not determine if low VWF is actually the underlying cause of the bleeding.

SPEAKER_01 10:25

Oh, it just confirms the bleeding exists.

SPEAKER_00 10:27

Exactly.

SPEAKER_01 10:27

Here's where it gets really interesting. These bad scores can be completely paradoxical when you compare kids and adults.

SPEAKER_00 10:34

Oh, definitely.

SPEAKER_01 10:35

Think about a five-year-old child. They might have a very low beat score on paper, not because they're healthy, but simply because they haven't lived long enough to experience a major hemostatic challenge.

SPEAKER_00 10:46

Precisely.

SPEAKER_01 10:46

They haven't had their wisdom teeth pulled, they haven't undergone a major abdominal surgery, they haven't gone through childbirth.

SPEAKER_00 10:52

The key exposure question a doctor must ask is always, what hemostatic challenges has this specific patient actually faced in their life? An adult will naturally have a higher score because they've simply had more years and more opportunities in life to bleed.

SPEAKER_01 11:06

But if type 1 VWD is an inherited condition, shouldn't family history give you the answer? Like if your parents have the mutated gene, you have it case closed.

SPEAKER_00 11:15

It is a strong piece of evidence, but it is not a shortcut. Type 1 VWD often shows what we call autosomal dominant inheritance.

SPEAKER_01 11:24

Meaning.

SPEAKER_00 11:25

This means you only need to inherit one copy of the altered gene from one parent to inherit the trait. However, it comes with variable penetrance.

SPEAKER_01 11:33

Variable penetrance meaning the gene is present in your DNA, but it expresses itself differently depending on the person.

SPEAKER_00 11:43

Yeah, exactly. A parent might carry the exact VWF variant in their genetics, but have almost zero bleeding symptoms throughout their entire life.

SPEAKER_01 11:51

That is wild.

SPEAKER_00 11:52

Family members might share the exact same low VWF blood levels on a lab report, but have vastly different actual bleeding risks in the real world. And there is a crucial sociological factor here too, especially regarding heavy menstrual bleeding.

SPEAKER_01 12:05

The normalization of symptoms.

SPEAKER_00 12:07

Yes. A family history of heavy menstrual bleeding is highly relevant medically. But a patient might severely underreport her bleeding to a doctor because within her family it's just completely normalized. If her mother, her sisters, and her aunts all experience the same heavy bleeding for 10 days a month, she might not even realize it's medically abnormal. She just assumed that is what a period is supposed to be.

SPEAKER_01 12:28

That is such an important point. It's not just about the biology in your veins, it's about the culture of the family you grew up in, masking the symptoms. So time over a lifetime matters. You need a long track record of symptoms. But the disease itself must change as we move through different life stages, right?

SPEAKER_00 12:46

Absolutely. Age and pregnancy are two of the most dramatic biological modifiers for this disease.

SPEAKER_01 12:51

Really? How so?

SPEAKER_00 12:52

As we age, our baseline VWF levels naturally rise. And during pregnancy, particularly late in the third trimester, those levels can spike substantially.

SPEAKER_01 13:01

Which sounds like fantastic news for a pregnant patient. They essentially look cured on paper right before delivery. Like they could safely get an epidural without fear of a spinal bleed.

SPEAKER_00 13:10

It can be great news, and those normalized levels often do allow the patient to safely receive noraxial anesthesia, but the postpartum danger is severe. Because pregnancy normalization does not cure type 1 VWD. Almost immediately after delivery, those VWF levels crash back down toward their original deficient baseline.

SPEAKER_01 13:30

So, right when the body is undergoing massive trauma and trying to heal from childbirth, the biological glue disappears.

SPEAKER_00 13:36

Yes. The patient looks perfectly normal late in pregnancy, but is incredibly vulnerable to severe delayed postpartum hemorrhage days later.

SPEAKER_01 13:45

That is terrifying.

SPEAKER_00 13:46

The timeline matters so much. The guidelines suggest checking levels in the third trimester, planning prospectively, and often using medications like tranxamic acid postpartum to proactively manage that crash risk.

SPEAKER_01 13:59

And what about aging? You mentioned baseline levels naturally rise as we get older. Does that mean a seven-year-old who is diagnosed at age 10 gets undiagnosed because their lab numbers look completely normal today?

SPEAKER_00 14:09

This raises a huge debate right now in hematology about undiagnosing VWD. If an older adult's numbers normalize, should we erase the label from their chart?

SPEAKER_01 14:18

Aaron Powell's a fair question.

SPEAKER_00 14:19

The consensus is that any reassessment needs to be incredibly thoughtful. If the original diagnosis was weak to begin with, say they had borderline lab results as a kid with almost no actual bleeding history, then reconsidering the diagnosis makes total sense.

SPEAKER_01 14:34

But if they have a real documented history of hemorrhaging after surgeries, exactly.

SPEAKER_00 14:39

If that older patient had a strong, reproducible bleeding history throughout their life and specialized treatments worked for them, then simply hitting a normal number on a lab test at age 65 shouldn't automatically erase their risk profile.

SPEAKER_01 14:54

Aaron Powell That makes a lot of sense.

SPEAKER_00 14:55

A diagnosis shouldn't exist forever out of sheer inertia, but it absolutely shouldn't be removed just because a single number improved on a Tuesday.

SPEAKER_01 15:02

It's all about the context of the whole life. Now let's talk about a specific curveball the text mentions. Up until now, we've been talking about the factory not producing enough cars, but there is a subvariant called type 1C.

SPEAKER_00 15:14

Ah, yes, type 1C.

SPEAKER_01 15:16

And this is a clearance problem. The classic example is Vicenza type VWD. The body makes the VWF perfectly fine, it releases it into the blood perfectly fine, but then it clears it out of the bloodstream way too fast.

SPEAKER_00 15:30

Yes, the production is completely normal. The retention is the problem.

SPEAKER_01 15:34

Think of it like a leaky bucket. If a patient is actively bleeding on an operating table and you pour water into the bucket, let's say you administer a medication called desmopressin to artificially boost their VWF levels. You look at the bucket one hour later and say, Great, it's full, the patient is safe.

SPEAKER_00 15:51

Right.

SPEAKER_01 15:51

But if you check that same bucket at four hours, all the water has leaked out. It's empty. If they are in hour three of a long surgery, they are in serious danger. Duration matters just as much as the peak.

SPEAKER_00 16:03

That is a life-saving distinction. If a surgical team only tests the blood one hour after giving the medication, they will get a false sense of security.

SPEAKER_01 16:10

Because they think the bucket is still full.

SPEAKER_00 16:12

Exactly. The guidelines specifically suggest using a desmopressin trial well before a surgery, with both one hour and four-hour post-infusion testing to confirm if this racket clearance leak is actually happening.

SPEAKER_01 16:26

With all these hiding spots, moving targets, and leaky buckets, how does a medical professional actually test for this and treat it without making a massive mistake?

SPEAKER_00 16:34

Well, the first thing to know is that routine screening tests will often lie to you.

SPEAKER_01 16:38

Really? Lie to you?

SPEAKER_00 16:40

Yeah. If a doctor runs your standard clotting screens things you might see on your physical chart as a PT or APTT, they are looking at the broad strokes of how your blood clots. But those broad strokes will often look completely normal in a type one VWD patient.

SPEAKER_01 16:54

So you're saying a routine physical essentially has blinders on when it comes to this disorder?

SPEAKER_00 16:58

Specific, targeted testing is required. You need the VWF antigen, the platelet-dependent VWF activity, and the factor eight activity. And even if a doctor orders the perfect tests, preanalytical errors can ruin everything.

SPEAKER_01 17:10

Pre-analytical errors. Meaning mistakes made before the blood even gets put into the testing machine.

SPEAKER_00 17:16

Yes. The literal physical journey of the blood sample matters. If a well-meaning phlebotomist draws your blood, puts the test tube on ice, and transports it in the cold, that cold temperature can actually reduce the VWF and factor VIII activity in the physical sample.

SPEAKER_01 17:32

Wait, are you serious? The weather outside the test tube can alter your diagnosis. That is wild.

SPEAKER_00 17:37

It leads directly to misclassification. The blood needs to be transported at ambient temperature, processed promptly, and interpreted by specialized labs with specific hemostasis expertise.

SPEAKER_01 17:48

Okay. I can see how a pill that stops clots from breaking down, like tranhexamic acid, works for a minor mucosal procedure like a tooth extraction.

SPEAKER_00 17:56

Right.

SPEAKER_01 17:57

But if I'm going in for major abdominal surgery, preserving a weak clot isn't going to cut it. I assume you have to actually fix the underlying VWF shortage at that point.

SPEAKER_00 18:06

You have to match the treatment to this specific hemostatic challenge. For major surgery, you need to actively raise the VWF and factor eighth levels in the blood.

SPEAKER_01 18:14

How do they do that?

SPEAKER_00 18:15

This is usually done with dysmopressin, which forces the body cells to release their own stored reserves of VWF into the bloodstream, or by giving actual VWF concentrates intravenously.

SPEAKER_01 18:27

Is dysmopressin a magic bullet then? Just squeeze the body's reserves and you're good to go?

SPEAKER_00 18:32

It is incredibly useful, but it carries real risks. It can cause hyponatremia, which is a dangerous drop in blood sodium levels. Oh wow. Because of this, it is risky for very young children and has to be used with extreme caution in older adults, especially those with cardiovascular issues or seizure disorders. And as we discussed with the leaky bucket, if you have a clearance issue, desmopressin won't protect you for long enough anyway.

SPEAKER_01 18:55

So what does this all mean? We started this deep dive looking for a clear, engineered X-ray of a disease. But what we found is that type 1 VWD isn't just low VWF. The author, William Aired, makes it incredibly clear that this is a relational diagnosis.

SPEAKER_00 19:10

Yes, very much so.

SPEAKER_01 19:11

Is low VWF, yes, but in the right proportional pattern, accompanied by the right real-world bleeding history, and evaluated under the right baseline physical conditions over time.

SPEAKER_00 19:22

If we connect this to the bigger picture, it changes how we view medical authority. The best diagnosis of type 1 VWD is not the one that blindly worships a numerical threshold on a lab printout. Right. The best diagnosis is the one that is transparent about clinical uncertainty, looks at the patient's entire life context, and ultimately helps that specific patient bleed less.

SPEAKER_01 19:43

It really forces a profound shift in perspective. We've just spent this time seeing how a supposedly rigid medical label like type 1 VWD fluctuates with stress, with age, with pregnancy, and even just running to catch a bus. And it forces us to ask how many other medical labels in our lives are we treating as permanent rigid stamps when they're actually just fleeting snapshots of our body's incredibly dynamic relationship with the world? Thank you for joining us on this deep dive. Keep asking questions and never be afraid to look beyond the numbers.